ScholarIQanswers from OpenAlex

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

PaperCitations, authors & open-access status

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout have?

ScholarIQcitation count

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout has 906 citations in the OpenAlex counts ScholarIQ stores.

When was Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout published?

ScholarIQyear

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout has 2018 year in the ScholarIQ index.

What is the open-access status of Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout?

ScholarIQoa status

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout has bronze oa status in the ScholarIQ index.

What is the DOI of Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout?

ScholarIQdoi

The DOI for Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout is on the source record.

What is the PMID of Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout?

ScholarIQpmid

The PMID for Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout is on the source record.

What is the OpenAlex record for Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout?

ScholarIQopenalex

The OpenAlex for Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial